I've read all three pages of your notes carefully. Here's my honest assessment and the complete model answer:
Your Notes - Marking Assessment
What you have written (honest evaluation):
| Section | Your Coverage | Quality | Marks Likely |
|---|
| Definition | Good - oncological clearance, margins, avoid amputation | Correct | ✓ |
| Goals of LSS | Good - primary goal, sacrifice NV if needed, optimal limb characteristics | Good | ✓ |
| Reconstruction techniques (overview) | Listed 4 types briefly | Superficial - no detail | Partial |
| PreOp planning & imaging | MRI gold std, CT, PET, angiography | Good | ✓ |
| Surgical principles | En-bloc resection, tumor capsule, plastic surgery for soft tissue | Good | ✓ |
| Prosthetic reconstruction | Endoprosthesis, modular, custom, expandable | Good | ✓ |
| LSS Advantages/Disadvantages | 4 each, listed well | Good | ✓ |
| Biological reconstruction | Autograft, allograft, recycled - adv/disadv | Good | ✓ |
| Hybrid construct | Present with adv/disadv | Good | ✓ |
| Arthrodesis | Brief, adequate | Adequate | ✓ |
| Rotationplasty | Present, brief | Adequate | ✓ |
| Complications | Early and late listed | Adequate | ✓ |
Estimated score: 6.5 - 7 / 10
What's missing or thin:
- No Enneking staging / MST staging - examiner WILL expect this
- No indications and contraindications properly structured
- No specific tumor examples (osteosarcoma, Ewing's, etc.)
- No comparison with amputation (functional outcomes data)
- Flap coverage / vascular reconstruction thin
- Rehabilitation details absent
- Outcomes data / MSTS score not mentioned
COMPLETE MODEL ANSWER - Limb Salvage Surgery (10 Marks)
INTRODUCTION / DEFINITION (0.5 marks)
Limb Salvage Surgery (LSS) is defined as the complete surgical resection of a malignant or aggressive bone/soft tissue tumor with oncologically safe margins, followed by structural and functional reconstruction of the limb defect, to avoid amputation while achieving equivalent or superior survival outcomes.
Historical note: Introduced by Enneking in the 1970s-80s; now performed in >80-90% of extremity bone tumors in specialist centers.
INDICATIONS AND CONTRAINDICATIONS (1 mark)
Indications:
- Primary malignant bone tumors (osteosarcoma - most common, Ewing's sarcoma, chondrosarcoma)
- High-grade soft tissue sarcomas
- Aggressive benign tumors (Giant Cell Tumor - recurrent/aggressive)
- Metastatic disease with good prognosis (renal, breast, thyroid)
Contraindications (absolute):
- Neurovascular bundle encasement (major vessels/nerves) - not just proximity
- Pathological fracture through tumor (contamination of entire compartment)
- Infection at operative site
- Inability to achieve adequate surgical margins
- Tumor extent that precludes functional reconstruction
- Patient preference / poor compliance
Relative contraindications:
- Skeletally immature patient (expandable prosthesis has changed this)
- Major vessel involvement (now addressed with vascular reconstruction)
PREOPERATIVE EVALUATION (1 mark)
Staging - Enneking Staging System (Surgical Staging System - SSS)
| Stage | Grade | Site | Metastasis |
|---|
| IA | Low (G1) | Intracompartmental (T1) | None (M0) |
| IB | Low (G1) | Extracompartmental (T2) | None (M0) |
| IIA | High (G2) | Intracompartmental (T1) | None (M0) |
| IIB | High (G2) | Extracompartmental (T2) | None (M0) |
| III | Any grade | Any site | Metastases (M1) |
LSS is generally applicable in Stages IA, IB, IIA, and selected IIB.
Imaging Protocol
- MRI (Gold Standard) - extent of soft tissue involvement, pseudocapsule, skip lesions, neurovascular proximity, intramedullary extent; defines resection margins
- CT scan - cortical destruction, matrix calcification, pulmonary metastases
- PET-CT / Bone scan - rule out systemic metastases, multifocal disease, skip lesions
- Angiography (selective) - neurovascular involvement, feeding vessel identification, pre-embolization for hypervascular tumors
Biopsy Principles
- Biopsy MUST be performed in the operating center that will do the definitive surgery
- Core needle biopsy preferred (Trucut) - less contamination than open biopsy
- Biopsy tract included in resection specimen (must lie in the surgical field)
- Poorly planned biopsy is the most preventable cause of unnecessary amputation
GOALS OF LSS (0.5 marks)
- Primary goal: Oncological clearance - tumor resection takes priority over reconstruction
- Wide en-bloc excision with negative surgical margins
- Sacrifice NV bundles if required for oncological clearance
- Reconstruct defect to restore function
Optimal salvaged limb characteristics:
- Functional (painless, stable, allows ADL)
- Cosmetically acceptable
- Durable long-term
MULTIMODAL TREATMENT (0.5 marks)
Neoadjuvant chemotherapy (before surgery) - for osteosarcoma and Ewing's:
- Reduces tumor volume, treats micrometastases
- Allows histological assessment of chemotherapy response (Huvos grade - predictor of survival)
- Grade III/IV response (>90% necrosis) = good prognosis
- Converts borderline resectable to resectable
Post-surgery: adjuvant chemotherapy ± radiotherapy (especially Ewing's sarcoma, soft tissue sarcoma)
SURGICAL PRINCIPLES (1 mark)
En-bloc Resection
- Tumor capsule integrity must be maintained at all times
- Wide margin: normal tissue cuff surrounding tumor on all sides
- Soft tissue defect managed with plastic surgery (rotational/free flap)
- Defect size does NOT compromise tumor resection - oncological margins not sacrificed for reconstruction convenience
Margin Classification (Enneking)
| Margin Type | Plane of Dissection | Risk of Local Recurrence |
|---|
| Intralesional | Through tumor | Very high |
| Marginal | Reactive zone / pseudocapsule | High |
| Wide | Normal tissue cuff | Low |
| Radical | Entire compartment | Very low |
Target: Wide margin minimum; radical for high-grade tumors when feasible.
RECONSTRUCTION METHODS (3 marks)
Factors Influencing Choice
- Defect size and location (diaphyseal vs. epiphyseal vs. periarticular)
- Joint involvement
- Patient age and growth potential (skeletal maturity)
- Available resources and surgeon expertise
- Soft tissue coverage available
- Prognosis (life expectancy)
1. Prosthetic (Endoprosthetic) Reconstruction - Most Common
Types:
| Type | Indication | Features |
|---|
| Modular megaprosthesis | Standard; periarticular tumors | Adjustable length intraoperatively; most popular |
| Custom / Patient-specific | Irregular bones (scapula, pelvis, spine) | Designed from CT/MRI; maintains oncological margins |
| Expandable prosthesis | Skeletally immature children | Non-invasive magnetic lengthening (Stanmore MUTARS, FITBONE); avoids leg length discrepancy |
Advantages: Immediate stability, early mobilization, preserved function, psychological and social benefits
Disadvantages: High cost, mechanical failure (loosening/fracture), infection risk (3-10%), implant failure rates higher than standard TJR, aseptic loosening long-term
2. Biological (Osseous) Reconstruction
Replaces bone with living tissue - better long-term biological integration
| Type | Source | Best for |
|---|
| Autograft (fibula, iliac crest) | Patient's own bone - small gaps | Small defects; free vascularized fibula for intercalary defects |
| Allograft | Cadaveric large bone | Large segmental/intercalary defects; osteoarticular reconstructions |
| Recycled/Devitalized autograft | Resected tumor bone - cleaned and sterilized (irradiation, autoclaving, pasteurization) | Reimplanted after tumor cells destroyed |
Advantages of biological reconstruction: Permanent integration, soft tissue attachment possible, better long-term function
Disadvantages: Long rehabilitation (months to years for incorporation), risk of non-union (20-30%), graft fracture, late collapse, infection
Best indication: Intercalary (mid-shaft) defects where joint is preserved; young patients where longevity of construct is critical
3. Hybrid Construct (Allograft-Prosthetic Composite - APC)
- Combines mechanical prosthesis with biological tissue (allograft)
- Example: Allograft-prosthetic composite for proximal femur/humerus
- Prosthesis provides immediate stability; allograft allows soft tissue/tendon reattachment
Advantages: Immediate weight bearing, lower prosthesis loosening (allograft distributes load), soft tissue attachment
Disadvantages: Technically demanding, higher failure chances, risk of non-union at allograft-host junction, infection
4. Arthrodesis (Fusion)
- Surgical fusion after tumor resection
- Durable, permanent, no wear or loosening
- Suitable for manual laborers, young active patients where prosthetic longevity is concern
- Disadvantage: Loss of joint mobility (significant functional limitation for hip/knee)
- Best for: Knee, ankle, shoulder (better function than flail joint)
5. Rotationplasty (Van Nes Procedure)
- Resection of distal femur/knee with 180° rotation of the lower limb
- Ankle joint acts as a biological knee joint after rotation
- Patient fitted with an external below-knee prosthesis
- Excellent functional outcomes in children, athletes
- Best indication: Distal femur / proximal tibia tumors in young children where growth plates must be spared
- Psychologically challenging (appearance) but functionally superior to above-knee amputation
6. Soft Tissue Reconstruction
- Rotational flaps (gastrocnemius, vastus lateralis) - local muscle coverage
- Free flaps (latissimus dorsi, rectus abdominis) - for large defects; requires microvascular anastomosis
- Plastic surgery collaboration is mandatory for complex soft tissue defects
COMPLICATIONS (1 mark)
Early Complications
| Complication | Notes |
|---|
| Infection / wound breakdown | Most devastating; rate 3-10%; deep infection often requires implant removal |
| Wound healing problems | Due to prior chemotherapy, radiation, poor vascularity |
| Neurovascular injury | During dissection; planned sacrifice if encased |
| Severe cases → Amputation | If margins not achieved or catastrophic infection |
Late Complications
| Complication | Notes |
|---|
| Local tumor recurrence | Most important; ~5-10% with wide margins; requires re-excision or amputation |
| Implant failure / Aseptic loosening | Metal fatigue, loosening at bone-implant interface |
| Graft fracture / non-union | Biological reconstructions; risk increases with radiation therapy |
| Leg length discrepancy | Especially in children; addressed with expandable prosthesis |
| Periprosthetic fracture | Especially at stem tips in megaprostheses |
OUTCOMES AND COMPARISON WITH AMPUTATION (0.5 marks)
MSTS (Musculoskeletal Tumor Society) Functional Score - 0-30 points:
- Pain, function, emotional acceptance, hand positioning/gait, lifting strength, walking ability
Key outcome data:
- 5-year survival: Equivalent between LSS and amputation for osteosarcoma (80-90% for localized disease with chemotherapy)
- Functional outcomes: LSS significantly superior on MSTS score
- Local recurrence: LSS ~5%, amputation ~2% - slightly higher but no difference in overall survival
- Quality of life: LSS superior - preserved body image, no phantom pain, better psychosocial outcomes
Conclusion: LSS is performed in modern oncological orthopaedics as a complex, multi-disciplinary procedure. It achieves equivalent survival with superior functional outcomes compared to amputation, but carries risks of local recurrence and implant failure. Success depends on appropriate staging, meticulous surgical technique, multidisciplinary team (orthopaedic oncologist, plastic surgeon, medical oncologist, radiation oncologist), and rigorous long-term surveillance.
Marks Allocation Guide for Examiner
| Section | Marks |
|---|
| Definition + Goals | 0.5 |
| Indications / Contraindications + Staging | 1.0 |
| Preoperative workup (imaging + biopsy principles) | 1.0 |
| Surgical principles (en-bloc, margins) | 1.0 |
| Reconstruction methods (all 5-6 with adv/disadv) | 3.0 |
| Multimodal treatment / Neoadjuvant chemotherapy | 0.5 |
| Complications | 1.0 |
| Outcomes + comparison with amputation | 1.0 |
| Total | 10 |
Your current notes would likely score 6.5-7/10. To reach 8.5-9/10, add: Enneking staging, biopsy principles, Huvos grading, MSTS outcome score, and more detail on each reconstruction option's specific indications.